A new FDA-approved obesity pill could offer a lower-cost alternative to injectable GLP-1 drugs like Ozempic and Mounjaro
Action for clinics: Incorporate digital monitoring and patient portal tools that allow patients to track progress and share results with their provider
Say goodbye to dull, tired skin and hello to a brighter, smoother, and more youthful appearance
This work was supported by the Leibniz Institute of Virology as part of the Leibniz ScienceCampus InterACt (supported by the BWFGB Hamburg and the Leibniz Association) and a Wellcome Trust Collaborative Award in Science (209250/Z/17/Z)
The many blood vessels identified as being activated by specific pathways following a given vessel injury require a regularly applicable therapy, with beneficial effects dependent on, but not limited to, occlusion of a particular vessel (Sikiric et al., 2018)
Reported Effects High local potency: Reported to be roughly ten-fold more potent than intact IGF-1 at stimulating cell proliferation and hypertrophy in culture, due to reduced binding-protein sequestration [1]
